What question did this study set out to answer?

This study aims to determine the molecular spectrum of hemoglobinopathies and develop a mutation map for Tunisia.

May 31, 2026Human MutationOpen Access

Mutation Spectrum of Hemoglobinopathies in Tunisia

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial reveals the mutation spectrum of hemoglobinopathies in Tunisia, highlighting public health implications.

This study aims to determine the molecular spectrum of hemoglobinopathies and develop a mutation map for Tunisia.
Investigated 260 Tunisian subjects using biochemical and molecular analyses.
Identified defects in the HBA, HBB, and HBD globin genes.
Created a mutation map for potential national prevention initiatives.
Identified twenty-one β-thalassemia mutations affecting HBA, HBD, and HBB genes.
Described 16 rare Hb variants for the first time among Tunisian patients, including Hb A2-Babinga.
Detected uncommon variants such as Hb Knossos, Hb Summer Hill, Hb Hope, and Hb Köln.

Moumni et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark